Publicaciones en colaboración con investigadores/as de National Cancer Institute (33)

2023

  1. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

    Annals of Epidemiology, Vol. 77, pp. 1-12

2022

  1. Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR-Driven Lung Cancer

    Advanced Science, Vol. 9, Núm. 26

2006

  1. Adrenomedullin: An Esoteric Juggernaut of Human Cancers

    Handbook of Biologically Active Peptides (Elsevier Inc.), pp. 453-458

2005

  1. Gene expression profiling identifies IL-13 receptor α2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin

    International Journal of Cancer, Vol. 114, Núm. 6, pp. 870-878

2004

  1. Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis

    Laboratory Investigation, Vol. 84, Núm. 8, pp. 999-1012

  2. Depressed adrenomedullin in the embryonic transforming growth factor-β1 null mouse becomes elevated postnatally

    International Journal of Developmental Biology, Vol. 48, Núm. 1, pp. 67-70

  3. Expression of complement factor H by lung cancer cells: Effects on the activation of the alternative pathway of complement

    Cancer Research, Vol. 64, Núm. 17, pp. 6310-6318

  4. Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: Apical secretion and distribution

    Experimental Eye Research, Vol. 78, Núm. 2, pp. 223-234

2003

  1. Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo

    Molecular and Cellular Endocrinology, Vol. 199, Núm. 1-2, pp. 179-187

2002

  1. Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostate and in prostate carcinoma

    Microscopy Research and Technique, Vol. 57, Núm. 2, pp. 98-104

  2. Adrenomedullin functions as an important tumor survival factor in human carcinogenesis

    Microscopy Research and Technique, Vol. 57, Núm. 2, pp. 110-119

  3. Adrenomedullin in mammalian embryogenesis

    Microscopy Research and Technique, Vol. 57, Núm. 1, pp. 40-54

  4. CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential

    Oncogene, Vol. 21, Núm. 28, pp. 4435-4447

2001

  1. Hyperplasia of alveolar neuroendocrine cells in rat lung carcinogenesis by silica with selective expression of proadrenomedullin-derived peptides and amidating enzymes

    Laboratory Investigation, Vol. 81, Núm. 12, pp. 1627-1638

  2. Peptidylglycine α-amidating monooxygenase- and proadrenomedullin-derived peptide-associated neuroendocrine differentiation are induced by androgen deprivation in the neoplastic prostate

    International Journal of Cancer, Vol. 94, Núm. 1, pp. 28-34

2000

  1. Effect of P-glycoprotein modulation with cyclosporin A on cerebrospinal fluid penetration of doxorubicin in non-human primates

    Cancer Chemotherapy and Pharmacology, Vol. 45, Núm. 3, pp. 207-212

  2. Expression of proadrenomedullin derived peptides in the mammalian pituitary: Co-localization of follicle stimulating hormone and proadrenomedullin N-20 terminal peptide-like peptide in the same secretory granules of the gonadotropes

    Journal of Neuroendocrinology, Vol. 12, Núm. 7, pp. 607-617

  3. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: A possible promotion mechanism of carcinogenesis

    Molecular Endocrinology, Vol. 14, Núm. 6, pp. 848-862

  4. New molecular strategies for early lung cancer detection

    Cancer Investigation, Vol. 18, Núm. 6, pp. 555-563

  5. Proadrenomedullin NH2-terminal 20 peptide (PAMP) and adrenomedullin bind to teratocarcinoma cells

    Peptides, Vol. 21, Núm. 1, pp. 101-107